Quick Takeaways
- BAKER BROS. ADVISORS LP filed SCHEDULE 13G/A for Candel Therapeutics, Inc. Common Stock, par value $0.01 per share (CADL).
- Disclosed ownership: 5%.
- Date of event: 31 Mar 2025.
BAKER BROS. ADVISORS LP - 31 Mar 2025 SCHEDULE 13G/A Report for Candel Therapeutics, Inc. Common Stock, par value $0.01 per share (CADL)
- Filing Manager
- BAKER BROS. ADVISORS LP
- Reporting Manager
- Baker Bros. Advisors LP
- Symbol
- CADL
- Shares outstanding
- 49,200,561 shares
- Disclosed Ownership
- 2,455,108 shares
- Ownership
- 5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 15 May 2025, 16:33:28 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 14 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"BAKER BROS. ADVISORS LP disclosed 5% ownership in Candel Therapeutics, Inc. Common Stock, par value $0.01 per share (CADL) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 14 Feb 2025.
- Current filing was accepted on 15 May 2025, 16:33.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 5% | 2,455,108 | 2,455,108 | 0 | /s/ Scott L. Lessing | Scott L. Lessing/ President, Baker Bros. Advisors (GP) LLC, its general partner | |
| Baker Bros. Advisors (GP) LLC | 5% | 2,455,108 | 2,455,108 | 0 | /s/ Scott L. Lessing | Scott L. Lessing/ President | |
| Julian C. Baker | 5% | 2,455,108 | 2,455,108 | 0 | /s/ Julian C. Baker | Julian C. Baker | |
| Felix J. Baker | 5% | 2,455,108 | 2,455,108 | 0 | /s/ Felix J. Baker | Felix J. Baker |